False000085152000008515202026-04-302026-04-30iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 30, 2026
_______________________________
Exponent, Inc.
(Exact name of registrant as specified in its charter)
_______________________________
| Delaware | 0-18655 | 77-0218904 |
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
149 Commonwealth Drive
Menlo Park, California 94025
(Address of Principal Executive Offices) (Zip Code)
(650) 326-9400
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
_______________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.001 per share | EXPO | Nasdaq Global Select Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company,indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On April 30, 2026, Exponent, Inc. issued a press release announcing its financial results for the first quarter ended April 3, 2026. The press release is attached hereto as Exhibit 99.1 and incorporated by reference.
Item 7.01. Regulation FD Disclosure.
On April 30, 2026, Exponent, Inc. announced that its Board of Directors has declared a quarterly cash dividend of $0.31 per share to be paid on June 18, 2026, to all common stockholders of record as of June 5, 2026. The Board of Directors also authorized an additional $50 million for share repurchases. This is in addition to the $17.7 million available for repurchase as of April 3, 2026. A copy of the press release announcing the dividend and additional share repurchase authorization is attached hereto as Exhibit 99.2 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
| | | | | |
| 99.1 | | Press Release dated April 30, 2026 | | |
| 99.2 | | Press Release dated April 30, 2026 | | |
| 104 | | Cover Page Interactive Data File (embedded within the Inline XBRL document) | | |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | Exponent, Inc. |
| | | |
| | | |
| Date: April 30, 2026 | By: | /s/ Richard L. Schlenker |
| | | Richard L. Schlenker |
| | | Executive Vice President and Chief Financial Officer |
| | | |
EXHIBIT 99.1
Exponent Reports First Quarter 2026 Financial Results
MENLO PARK, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2026 ended April 3, 2026.
“Exponent delivered double-digit growth in revenues and earnings during the first quarter, reflecting the strength of our multidisciplinary portfolio and increased demand for our specialized expertise across industries,” stated Dr. Catherine Corrigan, President and Chief Executive Officer. “Growth was driven by proactive engagements, including user research studies for consumer electronics clients integrating AI into their devices, as well as risk management work for utility clients evaluating asset performance under extreme weather conditions. Reactive engagements also contributed to our growth, with increased dispute-related and failure analysis demand across construction projects, energy facilities, and medical devices.
“The integration of AI and other advanced technologies into physical products and performance-critical systems, combined with rising expectations for safety and reliability, is driving increased reliance on Exponent’s specialized expertise. At the same time, trends in energy demand, infrastructure risk, and innovation continue to support demand for our deep technical capabilities, reinforcing our essential role in helping clients navigate complex, high-stakes decisions,” Dr. Corrigan continued.
First Quarter Financial Results
Total revenues and revenues before reimbursements for the first quarter of 2026 increased 14% to $166.3 million and 10% to $151.8 million, respectively, as compared to $145.5 million and $137.4 million in the first quarter of 2025.
Net income increased to $29.6 million, or $0.59 per diluted share, in the first quarter of 2026, as compared to $26.7 million, or $0.52 per diluted share, in the same period of 2025. During the quarter, Exponent realized a negative tax impact associated with share-based awards of $0.9 million as compared to $0.5 million in the first quarter of 2025. Inclusive of the negative tax impact, Exponent's consolidated tax rate was 30.2% in the first quarter, as compared to 29.4% for the same period in 2025.
EBITDA1 increased to $43.1 million, or 28.4% of net revenues, in the first quarter of 2026, as compared to $37.5 million, or 27.3% of net revenues in the first quarter of 2025.
During the first quarter of 2026, Exponent paid $16.6 million in dividends, repurchased $78.8 million of common stock, and closed the period with $118.6 million in cash and cash equivalents.
In a separate press release today, Exponent announced its quarterly cash dividend of $0.31 to be paid on June 18, 2026, and reiterated its intent to continue to pay quarterly dividends. Additionally, Exponent’s Board of Directors approved an increase in the current stock repurchase program of $50 million. This is in addition to the $17.7 million available for repurchases as of April 3, 2026.
Business Overview
Exponent’s engineering and other scientific segment represented 85% of the Company’s revenues before reimbursements in the first quarter of 2026. Revenues before reimbursements in this segment increased 12% in the first quarter, compared to the prior year period. Growth during the quarter was driven by user research studies in consumer electronics and risk management in the utilities sector, along with reactive engagements in the energy and life sciences sectors.
Exponent’s environmental and health segment represented 15% of the Company’s revenues before reimbursements in the first quarter. Revenues before reimbursements in this segment increased 2% in the first quarter, compared to the prior year period. Growth in this segment was primarily driven by Exponent’s regulatory consulting in the chemical industry.
Business Outlook
“Exponent delivered a strong first quarter, with 5% year-over-year headcount growth, 76% utilization, and strong rate realization driving growth,” commented Richard Schlenker, Executive Vice President and Chief Financial Officer. “We are encouraged by the market opportunities and remain confident in the long-term growth trajectory of the business.”
For the second quarter of fiscal 2026 as compared to the same period one year prior, Exponent anticipates:
- Revenues before reimbursements to grow in the high-single digits; and,
- EBITDA1 to be 27.0% to 27.8% of revenues before reimbursements.
For the full fiscal year 2026 as compared to fiscal year 2025, Exponent is maintaining its guidance and anticipates:
- Revenues before reimbursements to grow in the high-single digits; and,
- EBITDA1 to be 27.6% to 28.1% of revenues before reimbursements.
“Exponent is well positioned to support the evolving needs of our clients as innovation accelerates and systems grow more complex, particularly as AI is increasingly embedded in the physical world,” Dr. Corrigan said. “These dynamics continue to drive demand for our differentiated multidisciplinary expertise, independent evaluation, and trusted insight.
“Our recent leadership evolution further strengthens our ability to capitalize on these opportunities,” Dr. Corrigan continued. John Pye brings visionary leadership and a proven track record of innovation, playing a key role in advancing our capabilities while remaining firmly grounded in the technical rigor and independence that define Exponent. Eric Anderson adds deep financial and operational expertise, along with a strong understanding of our business and strategy. Rich Schlenker will continue to serve as Executive Vice President and has been nominated for election to the Board of Directors. Supported by our exceptional talent and distinct position in the marketplace, Exponent is well positioned to build on our momentum and deliver long-term value for our clients and shareholders.”
Today's Conference Call Information
Exponent will discuss its financial results in more detail on a conference call today, Thursday, April 30, 2026, starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. The audio of the conference call is available by dialing (844) 481-2781 or (412) 317-0672. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent website, or by dialing (855) 669-9658 or (412) 317-0088 and entering passcode 4146822#.
Use of non-GAAP Financial Measures 1
EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation, and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income, and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present, and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position, or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.
Exponent has provided its outlook regarding EBITDA as a percentage of revenues before reimbursements. The Company has not reconciled this non-GAAP financial measure to the corresponding GAAP financial measure because guidance for the various reconciling items is not provided and the Company is unable to estimate with reasonable certainty the effect of these items without unreasonable effort. For example, the Company is unable to estimate with reasonable certainty the impact of equity awards on Exponent’s taxes without unreasonable effort. These items are uncertain, depend on various factors, and may have a material effect on Exponent’s results computed in accordance with GAAP. A reconciliation between the historical GAAP and non-GAAP financial measures presented in this release is provided in the financial tables at the end of this release.
About Exponent
Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.
Exponent's consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent's offices in North America, Asia, and Europe. Exponent's consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.
Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.
Forward Looking Statements
This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.
Source: Exponent, Inc.
| EXPONENT, INC. |
| CONDENSED CONSOLIDATED STATEMENTS OF INCOME |
| For the Quarters Ended April 3, 2026 and April 4, 2025 |
| (unaudited) |
| (in thousands, except per share data) |
| | | | |
| | |
| | Quarters Ended |
| | April 3, | | April 4, |
| | 2026
| | 2025
|
| | | | |
| Revenues | | | |
Revenues before reimbursements
| $ | 151,817 | | | $ | 137,437 | |
Reimbursements
| | 14,486 | | | | 8,070 | |
| | | | |
Revenues
| | 166,303 | | | | 145,507 | |
| | | | |
| Operating expenses | | | |
Compensation and related expenses
| | 91,409 | | | | 75,903 | |
Other operating expenses
| | 12,825 | | | | 12,095 | |
Reimbursable expenses
| | 14,486 | | | | 8,070 | |
General and administrative expenses
| | 6,204 | | | | 5,007 | |
| | | | |
Total operating expenses
| | 124,924 | | | | 101,075 | |
| | | | |
Operating income
| | 41,379 | | | | 44,432 | |
| | | | |
| Other income | | | |
Interest income, net
| | 1,718 | | | | 2,714 | |
Miscellaneous income (expense), net
| | (758 | ) | | | (9,386 | ) |
| | | 960 | | | | (6,672 | ) |
| | | | |
Income before income taxes
| | 42,339 | | | | 37,760 | |
| | | | |
| Income taxes | | 12,770 | | | | 11,110 | |
| | | | |
| | | | |
Net income
| $ | 29,569 | | | $ | 26,650 | |
| | | | |
| | | | |
| Net income per share: | | | |
Basic
| $ | 0.59 | | | $ | 0.52 | |
Diluted
| $ | 0.59 | | | $ | 0.52 | |
| | | | |
| Shares used in per share computations: | | | |
Basic
| | 49,790 | | | | 51,283 | |
Diluted
| | 50,119 | | | | 51,650 | |
| | | | |
| EXPONENT, INC. |
| CONDENSED CONSOLIDATED BALANCE SHEETS |
| April 3, 2026 and January 2, 2026 |
| (unaudited) |
| (in thousands) |
| | | | |
| | | | |
| | April 3, | | January 2, |
| | 2026
| | 2026
|
| Assets | | | |
| Current assets: | | | |
Cash and cash equivalents
| $ | 118,553 | | | $ | 221,930 | |
Accounts receivable, net
| | 197,336 | | | | 181,507 | |
Prepaid expenses and other assets
| | 24,999 | | | | 24,143 | |
Total current assets
| | 340,888 | | | | 427,580 | |
| Property, equipment and leasehold improvements, net | | 71,875 | | | | 71,981 | |
| Operating lease right-of-use asset | | 70,451 | | | | 73,376 | |
| Goodwill | | 8,607 | | | | 8,607 | |
| Other assets | | 195,560 | | | | 195,975 | |
Total assets
| $ | 687,381 | | | $ | 777,519 | |
| | | | |
| Liabilities and Stockholders' Equity | | | |
| Current liabilities: | | | |
Accounts payable and accrued liabilities
| $ | 37,354 | | | $ | 30,942 | |
Accrued payroll and employee benefits
| | 82,561 | | | | 121,302 | |
Deferred revenues
| | 15,568 | | | | 18,868 | |
Operating lease liability
| | 6,715 | | | | 6,890 | |
Total current liabilities
| | 142,198 | | | | 178,002 | |
| Other liabilities | | 132,523 | | | | 133,232 | |
| Operating lease liability | | 74,323 | | | | 75,944 | |
Total liabilities
| | 349,044 | | | | 387,178 | |
| | | | |
| Stockholders' equity: | | | |
Common stock
| | 66 | | | | 66 | |
Additional paid-in capital
| | 386,329 | | | | 369,747 | |
Accumulated other comprehensive loss
| | (2,571 | ) | | | (2,290 | ) |
Retained earnings
| | 682,013 | | | | 668,423 | |
Treasury stock, at cost
| | (727,500 | ) | | | (645,605 | ) |
Total stockholders' equity
| | 338,337 | | | | 390,341 | |
Total liabilities & stockholders' equity
| $ | 687,381 | | | $ | 777,519 | |
| | | | |
| EXPONENT, INC. |
| EBITDA and EBITDAS (1) |
| For the Quarters Ended April 3, 2026 and April 4, 2025 |
| (unaudited) |
| (in thousands) |
| | | | | |
| | | |
| | Quarters Ended | |
| | April 3, | | April 4, | |
| | 2026
| | 2025
| |
| | | | | |
| Net Income | $ | 29,569 | | | $ | 26,650 | | |
| | | | | |
| Add back (subtract): | | | | |
| | | | | |
Income taxes
| | 12,770 | | | | 11,110 | | |
Interest income, net
| | (1,718 | ) | | | (2,714 | ) | |
Depreciation and amortization
| | 2,515 | | | | 2,492 | | |
| | | | | |
EBITDA (1)
| | 43,136 | | | | 37,538 | | |
| | | | | |
Stock-based compensation
| | 9,058 | | | | 8,179 | | |
| | | | | |
EBITDAS (1)
| $ | 52,194 | | | $ | 45,717 | | |
| | | | | |
| | | | | |
| | | | | |
| (1) EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. |
EXHIBIT 99.2
Exponent Declares Regular Quarterly Dividend for Q2 2026 and Increases Stock Repurchase Authorization by $50 Million
MENLO PARK, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.31 per share of common stock to be paid on June 18, 2026 to all common stockholders of record as of June 5, 2026.
Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent’s Board of Directors.
In addition, Exponent’s Board of Directors increased the Company’s authority to repurchase shares of its common stock by $50 million. This is in addition to the $17.7 million available for repurchase as of April 3, 2026.
“Exponent’s quarterly cash dividend and increased share repurchase authorization reflects our continued commitment to returning capital to our shareholders,” commented Dr. Catherine Corrigan, President and Chief Executive Officer. “Supported by strong profitability and the strength of our balance sheet, we are well positioned to continue our disciplined capital allocation strategy and drive long-term value to shareholders.”
About Exponent
Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.
Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.
Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.
Forward Looking Statements
This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.
